Alunbrig® (brigatinib)
for Lung Cancer

Alunbrig (brigatinib) is an antineoplastic medicine used to treat metastatic non-small cell lung cancer (NSCLC) in patients with an abnormal ALK gene. Alunbrig works by slowing or stopping the growth of cancer cells, helping the body to destroy them.

Heart
Other top medicines used to treat Lung Cancer